A Molecular Analysis of Fecal and Mucosal Bacterial Communities in Irritable Bowel Syndrome

2009 ◽  
Vol 55 (2) ◽  
pp. 392-397 ◽  
Author(s):  
Caroline Codling ◽  
Liam O’Mahony ◽  
Fergus Shanahan ◽  
Eamonn M. M. Quigley ◽  
Julian R. Marchesi
2011 ◽  
Vol 141 (5) ◽  
pp. 1792-1801 ◽  
Author(s):  
Mirjana Rajilić–Stojanović ◽  
Elena Biagi ◽  
Hans G.H.J. Heilig ◽  
Kajsa Kajander ◽  
Riina A. Kekkonen ◽  
...  

F1000Research ◽  
2018 ◽  
Vol 7 ◽  
pp. 1029 ◽  
Author(s):  
Stacy Menees ◽  
William Chey

Irritable bowel syndrome (IBS) is one of the most common functional gastrointestinal disorders encountered in clinical practice. It is a heterogeneous disorder with a multifactorial pathogenesis. Recent studies have demonstrated that an imbalance in gut bacterial communities, or “dysbiosis”, may be a contributor to the pathophysiology of IBS. There is evidence to suggest that gut dysbiosis may lead to activation of the gut immune system with downstream effects on a variety of other factors of potential relevance to the pathophysiology of IBS. This review will highlight the data addressing the emerging role of the gut microbiome in the pathogenesis of IBS and review the evidence for current and future microbiome based treatments


2012 ◽  
Vol 4 (2) ◽  
pp. 242-247 ◽  
Author(s):  
Ana Durbán ◽  
Juan J. Abellán ◽  
Nuria Jiménez-Hernández ◽  
Patricia Salgado ◽  
Marta Ponce ◽  
...  

2001 ◽  
Vol 120 (5) ◽  
pp. A399-A399
Author(s):  
J STEENS ◽  
P SCHAAR ◽  
C LAMERS ◽  
A MASCLEE

2001 ◽  
Vol 120 (5) ◽  
pp. A284-A284
Author(s):  
B NAULT ◽  
S SUE ◽  
J HEGGLAND ◽  
S GOHARI ◽  
G LIGOZIO ◽  
...  

2001 ◽  
Vol 120 (5) ◽  
pp. A637-A637
Author(s):  
Y RINGEL ◽  
D DROSSMAN ◽  
T TURKINGTON ◽  
B BRADSHAW ◽  
R COLEMAN ◽  
...  

2001 ◽  
Vol 120 (5) ◽  
pp. A634-A634 ◽  
Author(s):  
K OLDEN ◽  
W CHEY ◽  
J BOYLE ◽  
E CARTER ◽  
L CHANG

Sign in / Sign up

Export Citation Format

Share Document